“It’s like a smart bomb, to use a military analogy,” Dr. John P. Sedelaar, a postdoctoral research fellow at Johns Hopkins University, said in a news release from the American Association for Cancer Research. “By retooling chemotherapy agents, we may be able to get more accurate treatment monitoring and follow-up.”
The study was to be presented at the association’s 100th annual meeting, in Denver.

The researchers looked at more than 500 women with non-Hodgkin lymphoma and found that, overall, those who drank wine before their diagnosis had a 76 percent five-year survival rate, compared with 68 percent for those who didn’t drink wine. The five-year, disease-free survival rate was 70 percent for wine drinkers and 65 percent for non-wine drinkers.

Researchers analyzed U.S. data on 699,751 adults with kidney failure who were placed on a kidney transplant list between 1995 and 2007. After about two years on the list, 122,785 (17.5 percent) of them had received a transplant. Median distance to the closest transplant center was 15 miles.